Meta-Analysis of One-Month Dual Antiplatelet Therapy Versus Standard Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention

The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) is still debated. Current American and European guidelines recommend at least 6 months of DAPT after drug-eluting stent placement in stable coronary artery disease, and at least 12 months after acute coronary syndrome.1,2 Recent advances with newer stent generations have helped reduce the duration of DAPT. A recent meta-analysis assessed short-term DAPT (1 to 3 months) versus standard DAPT (12 to 24 months) and reported lower bleeding risks with similar ischemic events using the abbreviated DAPT duration.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research